Month: June 2021

Palliare

Seroba Leads $8M Series A Investment into Palliare

Galway, Ireland.  28 June 2021.  Palliare, an emerging company with the vision to create a safer operating room, has announced the closing of an oversubscribed $8 million Series A funding round. The round was led by leading European Life Sciences Venture Capital firm Seroba Life Sciences, with participation from Luxembourg-based SCM AD Ventures, Western Development …

Seroba Leads $8M Series A Investment into Palliare Read More »

Quantasc

Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

Alcester, England & Beverly, Mass., USA.  June 23, 2021.  Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a …

Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System Read More »

Fusion Round

Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434.

Hamilton, Ontario and Boston.  June 14, 2021.    Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the presentation of preliminary Phase 1 data from the single-dose portion of the study at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Virtual Annual Meeting.  The presentations and …

Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434. Read More »

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top